News

Filter

201 to 210 of 96934 results

Janssen collaborating International Union Against Tuberculosis and Lung Disease on Sirturo study

Janssen collaborating International Union Against Tuberculosis and Lung Disease on Sirturo study

06-11-2014

US health care giant Johnson & Johnson’s Europe-based subsidiary is to collaborate with the International…

bedaquilineJanssenPharmaceuticalResearchRespiratory and PulmonarySirturo

Genmab reports nine month interim results, including $31 million revenue increase on 2013

Genmab reports nine month interim results, including $31 million revenue increase on 2013

06-11-2014

Danish biotech company Genmab has reported its nine-month interim results, including an increase in revenue…

BiotechnologydaratumumabDenmarkDuoBodyFinancialGenmabOfatumumab Injection

Actavis third-qtr sales rocket, but loss posted

Actavis third-qtr sales rocket, but loss posted

05-11-2014

Ireland-headquartered generics drug major Actavis today reported net revenue leapt 83% to $3.7 billion…

ActavisFinancialGenerics

Vertex seeks regulatory approval for lumacaftor/ivacaftor combination for CF

05-11-2014

US biotech firm Vertex Pharmaceuticals has filed for marketing approval for a fully co-formulated combination…

BiotechnologyEuropeivacaftorlumacaftorRare diseasesRegulationUSAVertex Pharmaceuticals

FDA responds to Public Citizen antacid petition from 2011

FDA responds to Public Citizen antacid petition from 2011

05-11-2014

The US Food and Drug Administration has responded to a 2011 petition from consumer rights advocacy group…

Gastro-intestinalsNexiumPharmaceuticalPrevacidPrilosecRegulationUSA

Isis Pharmaceuticals receives first $7.5 million milestone payment from AstraZeneca for ISIS-STAT3

Isis Pharmaceuticals receives first $7.5 million milestone payment from AstraZeneca for ISIS-STAT3

05-11-2014

US pharma company Isis Pharmaceuticals has earned the first of two milestone payments from Anglo-Swedish…

AstraZenecaIsis PharmaceuticalsISIS-STAT3RxOncologyPharmaceuticalResearchUSA

New products do well, but sales and profit down at Lundbeck

New products do well, but sales and profit down at Lundbeck

05-11-2014

In what was clearly a difficult period for Danish CNS specialist Lundbeck due to patient expiries, the…

EuropeFinancialLundbeckNeurologicalPharmaceutical

201 to 210 of 96934 results

Parexel

Parexel

Back to top